Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP930412.RApEp6fbo3T7-VbhKaQR_oAPBgbC2GEw3V-cmTT9z5r6k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP930412.RApEp6fbo3T7-VbhKaQR_oAPBgbC2GEw3V-cmTT9z5r6k130_assertion type Assertion NP930412.RApEp6fbo3T7-VbhKaQR_oAPBgbC2GEw3V-cmTT9z5r6k130_head.
- NP930412.RApEp6fbo3T7-VbhKaQR_oAPBgbC2GEw3V-cmTT9z5r6k130_assertion description "[In the present study, we investigated the levels of two major endocannabinoids, anandamide and 2-arachidonylglycerol (2-AG), and their receptors, CB1 and CB2, in human low grade glioma (WHO grade I-II) tissues, high grade glioma (WHO grade III-IV) tissues, and non-tumor brain tissue controls.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP930412.RApEp6fbo3T7-VbhKaQR_oAPBgbC2GEw3V-cmTT9z5r6k130_provenance.
- NP930412.RApEp6fbo3T7-VbhKaQR_oAPBgbC2GEw3V-cmTT9z5r6k130_assertion evidence source_evidence_literature NP930412.RApEp6fbo3T7-VbhKaQR_oAPBgbC2GEw3V-cmTT9z5r6k130_provenance.
- NP930412.RApEp6fbo3T7-VbhKaQR_oAPBgbC2GEw3V-cmTT9z5r6k130_assertion SIO_000772 22176552 NP930412.RApEp6fbo3T7-VbhKaQR_oAPBgbC2GEw3V-cmTT9z5r6k130_provenance.
- NP930412.RApEp6fbo3T7-VbhKaQR_oAPBgbC2GEw3V-cmTT9z5r6k130_assertion wasDerivedFrom befree-20140225 NP930412.RApEp6fbo3T7-VbhKaQR_oAPBgbC2GEw3V-cmTT9z5r6k130_provenance.
- NP930412.RApEp6fbo3T7-VbhKaQR_oAPBgbC2GEw3V-cmTT9z5r6k130_assertion wasGeneratedBy ECO_0000203 NP930412.RApEp6fbo3T7-VbhKaQR_oAPBgbC2GEw3V-cmTT9z5r6k130_provenance.